Company Filing History:
1 out of 3 
1 out of 2 Years Active: 2025
Title: Sebastiano Pasqualato: Innovator in E3 Ligase Inhibition
Introduction
Sebastiano Pasqualato is a notable inventor based in Milan, Italy. He has made significant contributions to the field of molecular oncology through his innovative research and patent work. His expertise lies in the development of compounds that target specific biological pathways, particularly in cancer treatment.
Latest Patents
Sebastiano Pasqualato holds a patent for "HECT E3 ligase inhibitors and uses thereof." This invention relates to tricyclic derivatives of formula (I), which are useful as inhibitors of HECT-domain-containing E3 ligases, specifically NEDD4. The patent also encompasses pharmaceutical compositions that include these compounds, their medical applications, and the processes for their preparation. He has 1 patent to his name.
Career Highlights
Throughout his career, Pasqualato has worked with esteemed institutions such as the IFOM (Fondazione Istituto Firc Di Oncologia Molecolare) and the IEO (Istituto Europeo Di Oncologia S.r.l.). His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Sebastiano has collaborated with notable colleagues, including Maurizio Pasi and Raffaella Amici. These partnerships have enriched his research endeavors and fostered innovation in the field of oncology.
Conclusion
Sebastiano Pasqualato is a distinguished inventor whose work in E3 ligase inhibition has the potential to impact cancer treatment significantly. His contributions to molecular oncology and his collaborations with leading institutions highlight his commitment to advancing medical science.